What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Cardiology
The scientist’s investigation covers issues in Internal medicine, Myocardial infarction, Cardiology, Acute coronary syndrome and Percutaneous coronary intervention.
When carried out as part of a general Myocardial infarction research project, his work on Reperfusion therapy is frequently linked to work in In patient, therefore connecting diverse disciplines of study.
As part of his studies on Cardiology, Stefan James often connects relevant areas like Stent.
His research integrates issues of ST elevation, Mortality rate, Coronary artery bypass surgery, Survival analysis and Angina in his study of Acute coronary syndrome.
The various areas that Stefan James examines in his Percutaneous coronary intervention study include Lower risk, Heart failure and Intensive care medicine.
His Clopidogrel research incorporates themes from Platelet aggregation inhibitor and Anesthesia.
His most cited work include:
- ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation (5547 citations)
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes (4782 citations)
- 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. (3099 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Cardiology, Myocardial infarction, Acute coronary syndrome and Percutaneous coronary intervention.
His Clopidogrel, Ticagrelor, Conventional PCI and Coronary artery disease study in the realm of Internal medicine interacts with subjects such as In patient.
The concepts of his Cardiology study are interwoven with issues in Surgery and Hazard ratio.
His biological study spans a wide range of topics, including Stroke, Randomized controlled trial, Heart failure and Confidence interval.
His Acute coronary syndrome research integrates issues from Clinical trial, Emergency medicine, Troponin T and Intensive care medicine.
His work carried out in the field of Percutaneous coronary intervention brings together such families of science as Stent and Heparin.
He most often published in these fields:
- Internal medicine (70.92%)
- Cardiology (60.19%)
- Myocardial infarction (43.23%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (70.92%)
- Cardiology (60.19%)
- Myocardial infarction (43.23%)
In recent papers he was focusing on the following fields of study:
Stefan James spends much of his time researching Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Conventional PCI.
His study in Internal medicine concentrates on Hazard ratio, Randomized controlled trial, Ticagrelor, Coronary artery disease and Acute coronary syndrome.
His Acute coronary syndrome research incorporates elements of P2Y12, Clinical trial and Intensive care medicine.
Stefan James combines subjects such as Odds ratio and Subgroup analysis with his study of Cardiology.
His research investigates the connection between Myocardial infarction and topics such as Heart failure that intersect with issues in Atrial fibrillation.
His Percutaneous coronary intervention research is multidisciplinary, incorporating elements of Stent, Restenosis, Heparin, Randomization and ST segment.
Between 2018 and 2021, his most popular works were:
- Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention : A Consensus Document From the Academic Research Consortium for High Bleeding Risk (189 citations)
- Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. (120 citations)
- Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting (80 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Myocardial infarction
- Surgery
Stefan James mostly deals with Internal medicine, Percutaneous coronary intervention, Myocardial infarction, Cardiology and Conventional PCI.
Internal medicine is closely attributed to Neurology in his research.
The study incorporates disciplines such as Angioplasty, Stent, Restenosis, Adverse effect and Intensive care medicine in addition to Percutaneous coronary intervention.
His Myocardial infarction research includes elements of Stroke, Thrombosis and Public health.
He has included themes like Aspirin and Comorbidity in his Cardiology study.
As part of one scientific family, Stefan James deals mainly with the area of Conventional PCI, narrowing it down to issues related to the Fractional flow reserve, and often Angina.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
